SEC Form 3 filed by new insider Novel Inspiration International Co., Ltd.
$IRIX
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/19/2025 |
3. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Series B Preferred Stock(1) | 03/19/2025(2) | (3) | Common Stock | 3,000,000(3) | (3) | D(4) | |
| Convertible Promissory Note | 03/19/2025(2) | 03/19/2028 | Series B Preferred Stock | 400,000(3) | $10(3) | D(4) | |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
| Explanation of Responses: |
| 1. This Form 3 is filed jointly by Novel Inspiration International Co., Ltd. ("Novel Inspiration") and Shih-Yao David Lin. Mr. Lin is the sole officer, director and stockholder of Novel Inspiration. |
| 2. Prior to the Issuer receiving certain required approval by the Issuer's stockholders (the "Requisite Stockholder Approval"), as of March 19, 2025, Novel Inspiration may only covert into 3,356,126 shares of Common Stock, which is the number of shares equal to 19.99% of the Issuer's total outstanding Common Stock on March 19, 2025. The Requisite Stockholder Approval was obtained on June 11, 2025 at the Issuer's 2025 annual meeting of stockholders. |
| 3. Novel Inspiration holds 600,000 shares of Series B Preferred Stock and a convertible promissory note that is convertible, at the option of Novel Inspiration, into 400,000 shares of Series B Preferred Stock. Each share of Series B Preferred Stock is convertible, at the option of Novel Inspiration, into five shares of Common Stock and has no expiration date. |
| 4. The securities are owned directly by Novel Inspiration. |
| Novel Inspiration International Co., Ltd, By: /s/ Shih-Yao David Lin, Chief Executive Officer | 01/08/2026 | |
| /s/ Shih-Yao David Lin | 01/08/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||